Covered recipient · General Payments record
MICHAEL S HALPIN
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2022
$1,099.39
- Reported across 59 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $209.56 | 11 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $139.94 | 6 |
| Bausch & Lomb Americas Inc. | $16.91 | 1 |
| Allergan Inc. | $13.71 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $13.61 | 1 |
| EYEVANCE PHARMACEUTICALS LLC | $13.12 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $12.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.36 | 04/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892723545 | CMS |
| ABBVIE INC. | $25.93 | 05/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892723549 | CMS |
| ABBVIE INC. | $28.81 | 05/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892723553 | CMS |
| ABBVIE INC. | $25.09 | 05/25/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892723557 | CMS |
| ABBVIE INC. | $29.35 | 06/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892723559 | CMS |
| ABBVIE INC. | $14.40 | 06/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 892723563 | CMS |
| Allergan, Inc. | $13.71 | 02/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 889901371 | CMS |
| Bausch & Lomb Americas Inc. | $16.91 | 04/27/2022 | Food and Beverage | Undisputed | 01/23/2026 | 957518741 | CMS |
| EYEVANCE PHARMACEUTICALS LLC | $13.12 | 02/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 896704549 | CMS |
| Novartis Pharmaceuticals Corporation | $12.27 | 02/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893723823 | CMS |
| Sun Pharmaceutical Industries Inc. | $13.61 | 06/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | 947854079 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.